JAMA paper on OpenEvidence highlights clinician use but raises unanswered questions

A new study published in JAMA examines how clinicians are employing the OpenEvidence platform, an artificial-intelligence-driven tool designed to assist medical decision-making.

The authors highlight early adoption patterns but also point out several gaps, noting that the evidence base for the system’s effectiveness remains incomplete and that further validation is needed.

The article, featured in STAT’s Health Tech newsletter, also references work by Isomorphic Labs, underscoring ongoing interest in AI applications across the life-sciences sector.